VALIDATION IMAGES
Human liver lysate probed with Integrin beta-1 (11A2) Monoclonal Antibody (bsm-52266R) at 1:1000 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
Flow cytometric analysis of HeLa cells with Integrin beta-1 (11A2 ) Monoclonal Antibody (bsm-52266R) at 1:50 dilution followed by secondary antibody incubation (red), compared with an unlabeled control (cells without incubation with primary antibody; black).
Paraformaldehyde-fixed and paraffin-embedded Human liver cancer tissue incubated with Integrin beta-1 (11A2) Monoclonal Antibody (bsm-52266R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human colon cancer tissue incubated with Integrin beta-1 (11A2) Monoclonal Antibody (bsm-52266R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse colon tissue incubated with Integrin beta-1 (11A2) Monoclonal Antibody (bsm-52266R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse stomach tissue incubated with Integrin beta-1 (11A2) Monoclonal Antibody (bsm-52266R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.